Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of Clinical Pharmacology
|
May 16, 2018
Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD
Rashmi Mehta, Eleni Pefani, Misba Beerahee, et al.
Advances in Therapy
|
January 10, 2018
Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life
Maggie Tabberer, David A Lomas, Ruby Birk, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
September 16, 2015
Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler
David Prime, Wilfried de Backer, Melanie Hamilton, et al.
ERJ Open Research
|
October 11, 2018
Preventing clinically important deterioration with single-inhaler triple therapy in COPD
Ian Naya, Chris Compton, Afisi S Ismaila, et al.
The European Respiratory Journal
|
July 16, 2016
A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol
Steven J Pascoe, David A Lipson, Nicholas Locantore, et al.
Advances in Therapy
|
September 7, 2017
Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial
Afisi S Ismaila, Ruby Birk, Dhvani Shah, et al.
ERJ Open Research
|
May 12, 2018
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
David M G Halpin, Ruby Birk, Noushin Brealey, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 24, 2017
Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease"
David A Lipson, Helen Barnacle, Ruby Birk, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 5, 2017
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease
David A Lipson, Helen Barnacle, Ruby Birk, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 27, 2017
Reply to Suissa and Ariel: The FULFIL Trial
David A Lipson, Helen Barnacle, Ruby Birk, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of Clinical Pharmacology
|
May 16, 2018
Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD
Rashmi Mehta, Eleni Pefani, Misba Beerahee, et al.
Advances in Therapy
|
January 10, 2018
Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life
Maggie Tabberer, David A Lomas, Ruby Birk, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
September 16, 2015
Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler
David Prime, Wilfried de Backer, Melanie Hamilton, et al.
ERJ Open Research
|
October 11, 2018
Preventing clinically important deterioration with single-inhaler triple therapy in COPD
Ian Naya, Chris Compton, Afisi S Ismaila, et al.
The European Respiratory Journal
|
July 16, 2016
A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol
Steven J Pascoe, David A Lipson, Nicholas Locantore, et al.
Advances in Therapy
|
September 7, 2017
Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial
Afisi S Ismaila, Ruby Birk, Dhvani Shah, et al.
ERJ Open Research
|
May 12, 2018
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
David M G Halpin, Ruby Birk, Noushin Brealey, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 24, 2017
Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease"
David A Lipson, Helen Barnacle, Ruby Birk, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 5, 2017
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease
David A Lipson, Helen Barnacle, Ruby Birk, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 27, 2017
Reply to Suissa and Ariel: The FULFIL Trial
David A Lipson, Helen Barnacle, Ruby Birk, et al.
Page
of 3